A post-mortem study of the anatomical region differences and age-related changes on Ca and Mg levels in the human brain by Correia, Hélder et al.
A post-mortem study of the anatomical region differences and 
age-related changes on Ca and Mg levels in the human brain  
 
Hélder Correiaa,1, Patrícia Ramosa,1, Agostinho Santosb,c,d,e, Nair Rosas Pintob, Ricardo 
Mendesb, Teresa Magalhãesb,c,d,f, Agostinho Almeidaa,* 
 
a REQUIMTE, Department of Chemical Sciences, Laboratory of Applied Chemistry, Faculty of Pharmacy, Porto 
University, Rua de Jorge Viterbo Ferreira 228, 4050-313, Porto, Portugal. 
b National Institute of Legal Medicine and Forensic Sciences, North Branch, Jardim Carrilho Videira, 4050-167, 
Porto, Portugal. 
c CENCIFOR – Forensic Science Center, Largo da Sé Nova, s/n, 3000-213, Coimbra, Portugal. 
d Faculty of Medicine, Porto University, Al. Prof. Hernâni Monteiro, 4200-319, Porto, Portugal. 
e School of Health Sciences, Minho University, Campus Gualtar, 4710-057, Braga, Portugal. 
f Biomedical Sciences Institute Abel Salazar, Porto University, Rua de Jorge Viterbo Ferreira 228, 4050-313, 
Porto, Portugal. 
 
1 These authors contributed equally to this work. 
 
∗ Corresponding author: 
Department of Chemical Sciences 
Laboratory of Applied Chemistry 
Faculty of Pharmacy 
Porto University 
Rua de Jorge Viterbo Ferreira 228 
4050-313, Porto 
Portugal 
Tel.: +351 22 042 86 67 
Fax: +351 22 200 39 77 
E-mail address: aalmeida@ff.up.pt  
2	  
	  
Abstract 
 
Calcium and magnesium levels in 14 different areas of the human brain [frontal cortex, superior and middle 
temporal gyri, caudate nucleus, putamen, globus pallidus, cingulated gyrus, hippocampus, inferior parietal 
lobule, visual cortex of the occipital lobe, midbrain, pons-locus coeruleus, medulla and cerebellum-dentate 
nucleus] of adult individuals (n=42; 71±12, range: 50-103 years old) without a known history of 
neurodegenerative, neurological or psychiatric disorder were studied. 
Considering the mean values for the 14 regions, Mg was present at ca. 2.3-fold higher levels than Ca (mean ± sd: 
527±34 µg/g versus 226±53 µg/g). Calcium distribution within the brain showed to be quite heterogeneous: 
highest levels were found in the occipital (306±156 µg/g) and frontal cortex (287±78 µg/g), while lowest levels 
were found in the medulla (186±70 µg/g) and cerebellum (145±42 µg/g). Higher Ca levels were found in women 
than in men (248±59 µg/g versus 213±46 µg/g; p<0.05). A tendency for a Ca levels increasing with age in all 
studied brain regions and in both genders was also observed. On the contrary, Mg presented a highly 
homogeneous distribution and seems to remain quite unchanged irrespective of ageing.  
 
 
Keywords: human brain; calcium; magnesium; ageing; post-mortem analysis. 
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1. Introduction 
As a result of longer life expectancy, neurodegenerative diseases (ND) will become leading diseases worldwide 
during the next decades [1]. Besides “natural” ageing, genetic predisposition and environmental factors [2], 
imbalances on major and trace element (both essential and toxic) homeostasis in particular areas of the brain 
have been identified as potentially responsible for the cognitive decline associated with normal ageing and the 
development of some ND [3,4], but the evidence is still fragmentary and its definite role remains unclear.  
Calcium (Ca) plays a central role in neuronal physiology. As an ubiquitous second messenger, Ca regulates 
energy production, gene expression, membrane excitability, dendrite development and synaptogenesis [5]. In 
particular, intracellular Ca ions play a major role in neurons as the trigger for neurotransmitter release [6], 
regulate neuronal plasticity underlying learning and memory and neuronal survival [7]. 
Besides being a critical cofactor in numerous enzymatic reactions, magnesium (Mg) is involved in several 
cellular processes, including ATP production, oxygen uptake, electrolyte balance, glucose metabolism, DNA 
transcription and protein synthesis [8]. Regarding central nervous system, Mg has a neuroprotective role as a 
blocker of the N-methyl-D-aspartate (NMDA) receptor ion channel, which regulates Ca2+ transport through the 
plasma membrane and prevents ischemic damage to neurons. Since neural activity depends on the Mg 
concentration, when glutamate is released under anoxia conditions, it acts as a neuromodulator and protect cells 
from excitotoxicity [9]. 
Disturbances in the homeostasis of cytosolic Ca have been implicated in the pathogenesis of several acute and 
chronic ND and in brain ageing [10-12]. Magnesium brain levels seem to be decreased in elderly people and 
some authors believe that such depletion, particularly in the hippocampus, may represent an important 
pathogenic factor of some ND [13,14]. 
Most of the current information about the relationship between metals and human brain functioning is based on 
animal studies [15,16] or relies on determinations in cerebrospinal fluid, whole blood or blood serum or plasma 
[15,17-21]. Studies on major metals (such as Ca and Mg) and trace elements levels in normal and pathological 
human brains are scarce, limited to a few brain areas [22-24] and/or involve a small number of subjects [25,26]. 
Additionally, and regarding the specific topic of the distribution of metals in brain, most of the published post-
mortem [22,26,27] and in vivo [28,29] studies are focused solely on iron. Therefore, more extensive elemental 
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mappings are needed in order to understand the specific roles of major biometals and trace elements in the 
human brain and to interpret the data obtained from ND patients. 
Based on this background, the main goal of the present study was to directly quantify Ca and Mg levels in 14 
different areas of the human brain in order to evaluate a) the regional anatomic differences and b) age-related 
changes in Ca and Mg levels. The results found in one Parkinson’s disease and two Alzheimer’s disease patients 
are also presented. 
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2. Materials and methods 
2.1. Subjects 
Brain samples were collected from men (n=27; 67±11 years old) and women (n=15; 77±12 years old) not 
registered in the Portuguese National Registry of Refusal to Organ Donation database and complying with all the 
current regulations regarding human tissue collection for scientific research purposes. 
Samples were obtained from individuals submitted to forensic autopsy exams during the first semester of 2012 at 
the North Branch (Porto) of the Portuguese National Institute of Legal Medicine (INML). Individuals from each 
of the following age groups were studied: 50-59 (n=10), 60-69 (n=10), 70-79 (n=10), 80-89 (n=9) and ≥90 (n=3) 
years old. Inclusion criteria were a) the absence of a history of known neurodegenerative, neurological or 
psychiatric disorders, b) the absence of injuries involving the central nervous system (CNS), and c) 
macroscopically normal tissues. 
Samples from two individuals with documented Alzheimer’s disease (women, 73 and 85 years old) and one with 
Parkinson’s disease (woman, 91 years old) were also collected. 
 
2.2. Sample collection 
Samples were collected by the pathologists at the INML following a standard protocol. 
To prevent sample contamination, all materials in contact with the samples, including the stainless steel tools 
used by the pathologists, were previously decontaminated with a 5% (v/v) nitric acid solution prepared from 
concentrated (≥69%) HNO3 (Sigma-Aldrich, Germany) and thoroughly rinsed with ultrapure water (resistivity 
18.2 MΩ.cm at 25 °C) produced by a Milli-Q water purification system (Millipore, USA). 
After removing the brain from the cranium, the contaminating blood was washed away with ultrapure water. The 
meninges were removed with plastic tweezers, and the brain was washed again with ultrapure water to minimise 
sample contamination with blood or cerebrospinal fluid. Since each brain hemisphere is divided in four 
neuroanatomically and functionally lobes, the function of the affected neurons determines the clinical features, 
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which can be grouped into two main categories: cognitive impairment (e.g. Alzheimer’s disease) and movement 
disorders (e.g. Parkinson’s disease).  
In order to establish an accurate diagnosis and study the relationship between the disease process and either the 
clinical features seen in life or the cause of death, Paine and Lowe [30] have recently proposed a post-mortem 
approach where 14 key areas are suggested to be studied (Fig. 1). In this study, samples from those key areas 
were obtained.  
	  
Fig. 1. Sampled brain regions, as suggested by Paine and Lowe [30]: frontal cortex (1), superior (2A) and middle 
(2B) temporal gyri, basal ganglia including the caudate nucleus (3A), pu- tamen (3B) and globus pallidus (3C), 
cingulated gyrus (4), hippocampus (5), inferior parietal lobule (6), visual cortex of the occipital lobe (7), 
midbrain (including the substantia nigra at the level of the third nerve) (8), pons-locus coeruleus (9), medulla 
(10) and cerebellum-dentate nucleus (11). 
 
Using decontaminated plastic knives, tissue fragments (approximately 1 cm3) were collected from the following 
brain areas: frontal cortex (1); superior (2A) and middle (2B) temporal gyri; basal ganglia, including the caudate 
nucleus (3A), putamen (3B) and globus pallidus (3C); cingulated gyrus (4); hippocampus (5); inferior parietal 
lobule (6); visual cortex of the occipital lobe (7); midbrain, including the substantia nigra at the level of the third 
nerve (8); pons (locus coeruleus) (9); medulla (10); and cerebellum (dentate nucleus) (11). Samples were stored 
in decontaminated polypropylene tubes (Sarstedt, Germany) at -4 ºC until analysis. 
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2.3. Sample pre-treatment 
After defrosting, the brain samples were thoroughly washed with ultrapure water and placed in a dry oven 
(Raypa, Spain) at 110 ºC until constant weight (ca. 24 hours). Dried samples (ca. 100-500 mg) were weighed 
directly in the microwave digestion vessels, previously decontaminated with 10% (v/v) HNO3 and thoroughly 
rinsed with ultrapure water. Samples were digested with 2.5 mL of concentrated (≥65% m/m) HNO3 
(TraceSELECT®, Fluka, France) and 1.0 mL of ≥30% (v/v) H2O2 solution (TraceSELECT®, Fluka, Germany) in 
an MLS 1200 Mega microwave oven (Milestone, Italy), equipped with an HPR 1000/10 rotor, and using the 
following power (W)/time (min) program: 250/1, 0/2, 250/5, 400/5 and 600/5. After cooling, sample solutions 
were made up to 50 mL with ultrapure water and stored in closed propylene tubes at 4 ºC until analysis. 
 
 
2.4. Calcium and magnesium determination 
The determination of Ca and Mg was performed by flame atomic absorption spectrometry (FAAS), using a 
PerkinElmer (Germany) Model 3100 instrument, with an oxidizing air-acetylene flame and Intensitron™ 
(PerkinElmer) hollow cathode lamps (operated at 10-mA for Ca and 6-mA for Mg) as light source (λ Ca=422.7 
nm; λ Mg=285.2 nm; slit width=0.7 nm).  
Calibration standards were prepared by diluting a commercial standard solution (1000 mg/L) of Ca (CertiPUR®, 
Merck, Germany) and Mg (SpectrosoL®, BDH, England) with acidified (0.2% v/v HNO3) ultrapure water. 
Calibration curves were obtained with five Ca and Mg calibration standards with concentrations ranging from 1 
to 5 mg/L and 0.1 to 0.5 mg/L, respectively. 
For analysis, the sample digests were previously diluted (20-fold for Mg and 2-fold for Ca) with ultra-pure 
water. A 10% (w/v) La solution, prepared by dissolution of La2O3 (Sigma-Aldrich, China) in concentrated (30%) 
HCl (Fluka, Switzerland), was added to all samples and standards (final concentration: 0.5%) in order to 
suppress interference from elements which give rise to stable oxysalts. 
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2.5. Analytical quality control 
Because human brain tissue is not available as a certified reference material (CRM) for Ca and Mg 
determination, human serum (Seronorm™ L-1 and L-2, Sero As, Norway) and dogfish liver (DOLT-4, from 
National Research Council, Canada) were used for analytical quality control purposes. CRMs were subjected to 
the same sample pre-treatment. The values obtained proved the accuracy of the analytical procedure (Table 1). 
One sample blank was performed in each microwave-assisted acid digestion series (10 samples). In total, 77 
sample blanks were run, and the mean value (Ca=0.00 µg/L; Mg=1.86 µg/L) was subtracted from the sample 
values.   
 
Table 1 
Results obtained in the determination of Ca and Mg in certified reference materials. 
 Ca Mg 
 
Acceptable range# Experimental value 
(mean±sd;n=3) 
Acceptable range# 
Experimental value 
(mean±sd;n=3) 
Serum L1 
(mg/L) 
90.2-101.8 
94±2.2 
19.1-22.1 
20.5±0.4 
Serum L2 
(mg/L) 
131-147 
138±2 
37.9-44.1 40.8±0.5 
DOLT-4 (µg/g) 680* 692±4 1500* 1510±12 
*Information value (i.e., value which could not be certified because of insufficient information to accurately 
assess uncertainties).# Acceptable range for ICP-AES determination (no data available for FAAS). 
 
 
2.6. Statistical analysis 
The descriptive statistical parameters and correlations were calculated using Microsoft Office Excel 2010 
(Microsoft Co., USA). The means were compared by unpaired Student’s t-test at α=0.05 significance level using 
GraphPad Prism 5 (GraphPad Software Inc., USA). 
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3. Results and discussion 
3.1. Anatomical region differences on Ca and Mg levels 
The studies regarding elemental levels in human brain are rather scarce. Our results for Ca and Mg (226±53 µg/g 
and 527±34 µg/g, respectively) are in good agreement with previously reported data [22,31]. 
The results (µg/g dry weight) for Ca and Mg in each of the 14 different brain regions studied are summarised in 
Table 2 and Table 3, respectively. 
Table 2. Ca levels (mean ± sd, μg/g dry weight) in 14 different regions of human brain (see footnote) of non-
diseased individuals (n = 42; 71 ± 12 years old) according to age group.  
Brain regions* All individuals 
Age groups 
[50-59] 
(n=10) 
[60-69] 
(n=10) 
[70-79] 
(n=10) 
[80-89] 
(n=9) 
≥90 
(n=3) 
1 287±78  228±42 269±44 291±72 317±96 375±109 
2A 254±91 186±63 253±85 242±38 325±128 335±47 
2B 221±68 188±51 258±76 266±62 241±47 434±165 
3A 250±108 224±76 194±100 258±98 287±190 236±25 
3B 202±70 161±64 194±90 210±43 225±59 274±76 
3C 256±193 162±53 228±145 230±137 321±193 578±468 
4 202±61 157±82 183±40 244±48 196±27 267±61 
5 255±105 219±118 233±76 259±84 262±67 416±217 
6 276±112 205±41 347±142 242±65 327±146 251±27 
7 306±156 265±76 229±68 273±120 392±224 509±195 
8 173±53 134±47 173±47 203±64 182±43 172±9 
9 184±80 178±59 135±50 196±73 195±80 296±162 
10 164±70 183±162 157±75 211±67 148±63 178±68 
11 145±42 131±29 157±61 157±36 139±61 180±70 
Mean Ca level in 
the 14 regions  226±53 193±19 233±35 246±54 256±60 321±48 
*1-Frontal cortex; 2A-Superior temporal gyrus; 2B-Middle temporal gyrus; 3A-Caudate nucleus, 3B-Putamen; 3C-Globus 
pallidus; 4-Cingulated gyrus; 5-Hippocampus; 6-Inferior parietal lobule; 7-Visual cortex of the occipital lobe; 8-Midbrain, 9-
Pons 10-Medulla; 11-Cerebellum. 
 
The Mg/Ca ratio found in the present study, ranging from 2.0 to 3.3, compares with Andrási et al. [22] data, who 
reported Mg/Ca ratios between 1.4 and 2.4. However, there are several studies reporting much lower ratios, with 
Mg and Ca present at similar levels. In an old study by Ward and Manson [32] significantly lower Mg levels 
were found in cerebral cortex and hippocampus from East Canada and United Kingdom populations, which led 
to a Mg/Ca ratio in the 1.0 - 1.2 range. In a study by Rajan et al. [25] Mg levels were even lower than Ca in 9 of 
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the 12 human brain regions studied, resulting in Mg/Ca ratios between 0.94 and 0.57. In a recent study by Tohno 
et al. [33] a much higher (ca. 18-fold) Ca level was found in basal ganglia (mean value: 4025 µg/g). Subjects in 
this study (n=45) were older (mean age: 83.3±7.5 years old versus 70.5± 12.2 years old in our study (n=42)), 
nevertheless the difference has to be considered significant. On the contrary, Mg level (429 µg/g) was quite 
similar. 
Table 3. Mg levels (mean ± sd, µg/g dry weight) in 14 different regions of human brain (see footnote) of non-
diseased individuals (n = 42; 71 ± 12 years old) according to age group.  
Brain regions* All individuals 
Age groups 
[50-59] 
(n=10) 
[60-69] 
(n=10) 
[70-79] 
(n=10) 
[80-89] 
(n=9) 
≥90 
(n=3) 
1 579±74 577±96 598±36 589±54 558±52 563±191 
2A 576±70 591±42 573±41 575±66 584±107 526±118 
2B 609±83 613±39 602±29 596±64 593±39 700±297 
3A 567±71 583±73 569±62 579±61 552±76 512±121 
3B 577±71 590±79 569±53 591±56 568±91 544±97 
3C 476±54 450±43 490±52 480±47 469±69 524±39 
4 535±87 522±123 508±115 563±47 528±31 586±67 
5 588±87 645±43 551±99 590±65 567±51 662±27 
6 557±57 570±43 527±44 582±70 538±58 578±48 
7 545±70 558±85 562±75 535±65 521±59 548±56 
8 448±45 440±72 446±35 452±23 450±50 465±20 
9 434±45 451±67 427±40 436±31 415±36 446±30 
10 437±78 440±44 423±35 507±97 385±77 396±39 
11 421±67 437±22 446±42 425±64 420±33 439±43 
Mean Ca level in the 
14 regions 527±34 533±32 521±29 537±31 513±40 535±27 
*1-Frontal cortex; 2A-Superior temporal gyrus; 2B-Middle temporal gyrus; 3A-Caudate nucleus, 3B-Putamen; 3C-Globus 
pallidus; 4-Cingulated gyrus; 5-Hippocampus; 6-Inferior parietal lobule; 7-Visual cortex of the occipital lobe; 8-Midbrain, 9-
Pons 10-Medulla; 11-Cerebellum. 
 
The results also showed that the Ca distribution is quite heterogeneous (Table 2). Regardless of age group, the 
highest levels were found in the frontal cortex (163-518 µg/g) and occipital cortex (109-762 µg/g) and the lowest 
in medulla (26-295 µg/g) and cerebellum (71-258 µg/g). On the contrary, results showed that brain Mg has a 
highly homogeneous distribution in the “non-diseased” adult human brain (Table 3). 
It has been shown that major metals and some trace element are heterogeneously distributed in the brain 
[24,27,31] and this pattern is probably related to their specific physiological functions on specific brain areas 
[34]. Concordant with our results, Duflou et al. [31] also found cerebellum as the brain region with lower Ca 
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content (90-310 µg/g) and the superior frontal gyrus (an area from frontal cortex) as the Ca richer region (140-
900 µg/g).  
Regarding Mg, Andrási et al. [35] reported a non-homogeneous distribution of Mg in normal human brain of 20 
individuals (mean age 70 years), but our data showed a highly constant Mg level in the 14 regions studied. Rajan 
et al. [25] also reported relatively constant Mg levels (483-872 µg/g dry weight)1, as well as for Ca (592-863 
µg/g dry weight), in different brain areas. 
 
 
3.2. Age-related changes on Ca and Mg levels 
Ageing is associated with a general decline in physiological functions. Amongst the different aspects of body 
deterioration, cognitive impairments, and particularly defects in learning and memory, represent one of the most 
frequent features in the elderly [14]. Neuronal properties and synaptic plasticity closely depend on ion exchanges 
between intra- and extracellular compartments. Changes in ion regulation during ageing may therefore 
participate in altering functional properties of neuronal networks [14].  
Considering the mean value of the results obtained for each of the 14 regions, a tendency for an age-related 
increase in brain levels was found for Ca but not for Mg (Fig. 2a and 3, respectively).  
This tendency for a direct correlation between Ca brain levels and age was observed in all the 14 regions studied, 
the most significant being found for the occipital cortex (r=0.453; p=0.003), globus pallidus (r=0.349; p=0.014) 
and middle temporal gyrus (r=0.616; p< 0.0001) (Fig. 2b-d). 
Hebbrecht et al. [24] also found a mild increase on Ca levels in the brainstem (medulla, pons and midbrain) and 
cerebral white matter (n=18 subjects; 7 to 79 years old). In the basal ganglia, the authors found that Ca levels 
remained fairly constant until the fifth decade, but thereafter a strong but variable increase was observed 
(p<0.01). These authors also reported a significant (p<0.05) Ca increase in cerebellum, but this increase was not 
so noticeable in our study (p=0.089). Another study, by Tohno et al. [33], regarding minerals in the basal 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 The authors reported their values as wet weight. We converted them into dry weight by using a dry/wet ratio of 0.211, as suggested by the 
authors. 
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ganglia, reported a significant (p=0.026) age-related increase of Ca levels in the putamen but not in the caudate 
nucleus or globus pallidus of non-diseased	  elderly individuals (n= 45; 70 to 101 years old). 
 
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
 
Fig. 2. Relationship between Ca levels [μg/g; mean value for the 14 brain areas of each individual (n = 42)] and 
age (years) (a) and Ca levels in the occipital cortex (b), globus pallidus (c) and middle temporal gyrus (d).  
 
Calcium ions fluxes across the plasma membrane and between intracellular compartments play critical roles in 
fundamental functions of neurons, including the regulation of neurite outgrowth and synaptogenesis, synaptic 
transmission, neuronal	  plasticity	  underlying	  learning	  and	  memory, and cell survival [7]. Products of energy 
c	  
a	   	  
d	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metabolism accumulating with age together with oxidative stress gradually impair Ca homeostasis, resulting in 
synaptic dysfunction, impaired plasticity and neuronal degeneration [36,37]. 
It has been hypothesized [24] that increased Ca levels in advanced age may be related to Ca-ATPase 
malfunction, as a consequence of altered membrane fluidity. Increased levels of free Ca presumably activate 
DNA fragmentation, characteristic of apoptosis.  
 
 
 
 
 
 
Fig. 3. Relationship between Mg levels [μg/g; mean value for the 14 brain areas of each in- dividual (n = 42)] 
and age (years).  
 
In our study, Mg showed quite unchanged levels (or a very slight decrease; see Fig. 3) with ageing in all studied 
regions. Available data are conflicting and either a positive [33,38] or negative [13] correlation between Mg 
brain levels and age have been reported.  
Magnesium dysregulation in brain ageing has received less attention than Ca, though ageing constitutes a risk 
factor for Mg deficit [14]. Magnesium reduces transmitter release at presynaptic fiber terminals and controls the 
activation of the N-methyl-D-aspartate receptor, which is critical for the expression of long-term changes in 
synaptic transmission. In addition, Mg is a cofactor of many enzymes localized either in neurons and glial cells 
that control neuronal properties and synaptic plasticity [14]. It is therefore likely that a change in Mg brain levels 
would significantly impair synaptic functions in the aged hippocampus. The experimental studies regarding this 
question remain too scarce but the data indicate that Mg is involved in age-related deficits in transmitter release, 
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neuronal excitability and in some forms of synaptic plasticity such as long-term depression of synaptic 
transmission and suggest that Mg deficit is a relevant factor for ageing-associated susceptibility to hippocampus 
decline [14]. 
3.3. Gender-related differences on Ca and Mg levels and smoking habits 
A few studies exists regarding gender-related differences on some trace element levels, namely Fe, in human 
brain [27,39,40] but studies concerning Ca and Mg are rather scarce. Some authors [41] consider two different 
type of gender-related differences in the elements levels of brain regions. The	   first	   one	   corresponds	   to	   a	  difference	   that	  was	  already	  present	   in	   the	  adulthood	  and	  persists	  up	   to	   the	  old	  age.	   In	   the	  second	   type,	  although	  the	  gender	  difference	  in	  the	  element	  levels	  was absent	  in	  the	  adulthood,	  it	  appears	  in	  the	  old	  age.	  In	  particular,	  the	  age-­‐related changes	  on	  the	  element	  levels	  after	  adulthood	  may	  be	  different between	  men	  and	  women.	  	  
In	   our	   study,	   the	   correlation	   between	   Mg	   (virtually	   constant)	   or	   Ca	   levels	   (a	   tendency	   for	   a	   steady	  increase)	   and	   age	   were	   similar	   for	   both	   men	   (slope:	   2.3;	   r=0.546;	   p=0.003)	   and	   women	   (slope:	   3.1;	  r=0.648;	  p=0.009)	  (Fig.	  4).	  	  
The mean value for Ca in the 14 regions were found significantly higher in women than men (248±59 µg/g 
versus 213±46 µg/g; p=0.0463) (Fig. 4a). This difference was particularly significant in the middle temporal 
(p=0.013), occipital cortex (p<0.0001) and cerebellum (p=0.039).  
No gender-related differences were observed for either total Mg levels (527±41 µg/g for women and 527±29 
µg/g for men; p=0.970) or Mg levels at any individual brain region studied. Also, no correlation was found 
between Mg levels and age in both genders (Fig. 4b).  
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Fig. 4. Relationship between the mean value for Ca (a) and Mg (b) (μg/g) in the 14 brain areas studied and age 
(years) in men ( ) and women (X).  
 
In a recent study, Tohno et al. [33] found a significantly higher Ca content in the caudate nucleus of women	  
(1.12-fold; p=0.028) but no differences in Mg levels. In	  our	   study,	   higher	  Ca	   levels	  were	   found	   in	   several	  brain	  regions,	  namely	  in	  the	  putamen	  (p=0.0043),	  occipital	  cortex	  (p<0.0001)	  and	  cerebellum	  (p=0.0217)	  of	   women.	   The cause and physiological significance of these gender-related differences in brain Ca levels 
remains to be elucidated. 
No significant differences were found in Mg levels between smokers and non-smokers (529±30 µg/g vs. 
526±42, p=0.8134). Regarding Ca, reduced levels were found in smokers (213±45 µg/g vs. 240±53, p=0.0456), 
which could be explained by a decreased intestinal Ca absorption in individuals with smoking habits [42,43]. 
	  
3.4. Neurodegenerative patients 
Changes on major and trace element levels have been correlated with neurological degenerative disorders such 
as Alzheimer’s disease (AD) and Parkinson’s disease (PD) [3,44,45]. In	  ND,	  cellular	  Ca2+-­‐regulating	  systems	  are	  usually	  disturbed.	  Oxidative	  stress,	  perturbed	  energy	  metabolism,	  and	  alterations	  of	  disease-­‐related	  proteins	  result	  in	  Ca2+-­‐dependent	  synaptic	  dysfunction,	  impaired	  plasticity,	  and	  neuronal	  death	  [7]. A role 
for Mg in both physiologic and pathological states of CNS has also become increasingly evident, supporting the 
a	   b	  
a	   b	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view that the intracellular free Mg2+ concentration is critical in normal cell function and ion concentration can 
change in response to various stimuli [9].  
During the sample collection period (first semester of 2012), brain samples from 2 AD and 1 PD patients were 
also obtained. Although no definite conclusions can be drawn, the results obtained (as the ratio between Ca and 
Mg levels in the ND patients and matched control subjects) are shown in Fig. 5.  
 
Fig. 5. Ratio between Ca (a) and Mg (b) levels in ND patients and matched control subjects.  
a	  
b	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Because of the above mentioned gender-related differences in Ca levels, only values for women in the “normal” 
(non-diseased) group were considered for comparison.  
Compared with control group, increased Ca levels were found in frontal cortex, superior temporal and inferior 
parietal in both AD patients. Although limited and not consistent in the two individuals, our results showed 
increased Ca levels in some brain regions of AD patients (Fig. 5a). 
Previously published studies have already described specific anatomical region changes on Ca levels. Leskovjan 
et al. [46] found increased levels of Ca in the amyloid plaques (one of the neuropathological hallmarks of the 
disease) of AD patients . Ward and Mason [32] also found increased Ca levels (1.6-fold) in hippocampus of AD 
patients (n=58). The exact meaning and implications of these imbalances remains unclear.  
Calcium dyshomeostasis has also been recently proposed as the primary age-related condition driving 
neurodegeneration in the sporadic form of PD supported by the demonstration that dopaminergic neurons 
expressing higher levels of protein buffers calbindin D28k, calretinin and parvalbumin seem to be resistant to 
degeneration in this disease [37]. Alfa-synuclein aggregates, neuropathological hallmarks of PD, potentiate 
neuronal Ca2+ dyshomeostasis and overload, which can be linked to glutamate excitotoxicity [36]. Compared to 
normal subjects of the same age sub-group, Ca was found decreased in all the studied regions of the PD patient 
studied, except in the globus pallidus, midbrain and medulla, where increased levels were found. 
In AD patient #1, it was observed a Mg decrease in the caudate nucleus, globus pallidus, hippocampus, medulla 
and cerebellum, while in patient #2 no differences were found. Since Mg	   levels	   were	   found	   decreased	   in	  several	  tissues of	  AD	  patients	  in	  clinical,	  experimental	  and	  autopsy	  studies	  [47],	  Mg depletion, particularly 
in the hippocampus, has been considered as an important pathogenic factor in AD [9].	  
Compared with the respective control group, no differences were found in Mg levels in the PD patient, excluding 
the frontal cortex, middle temporal, hippocampus, inferior parietal and midbrain, where decreased levels were 
found.  
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4. Conclusions 
This study, involving the direct determination of Ca and Mg in 14 different brain regions of 42 non-diseased 
individuals (70.5± 12.2 years old) provides update data on the actual levels, regional distribution and age-related 
changes of these two important biometals in the human brain, contributing for defining the “normal” levels, a 
fundamental step in order to allow future comparisons with data obtained from individuals affected by ND. 
Globally (i.e., considering the mean value for the 14 regions of the 42 individuals), Mg levels were found ca. 
2.3-fold higher than Ca (527±34 µg/g versus 226±53 µg/g).  
Calcium showed significant heterogeneous distribution, with the highest levels at the frontal (163-518 µg/g) and 
occipital cortexes (109-762 µg/g) and the lowest at the medulla (26-295 µg/g) and cerebellum (71-258 µg/g). On 
the contrary, Mg showed highly stable levels in all the studied regions. 
A significant age-related tendency for increased Ca levels was found, supporting that it may be involved in age-
related neurodegenerative processes. The globus pallidus, occipital cortex and middle temporal gyrus were the 
brain regions where this direct correlation reached higher significance. On the contrary, Mg showed remarkably 
stable levels along the age range studied.  
Also considering the whole brain mean values, slightly higher Ca levels were found in the female subgroup. 
Once again, such difference was absent for Mg. 
Together, these findings show a different behaviour for Ca and Mg in the normal (non-diseased) human brain, 
with Mg levels being much more stable, regardless of gender, age and brain region. 
Differences in Mg and Ca levels in some brain regions of one PD and two AD patients were found, suggesting 
that dyshomeostasis of these metals may play a role in ND, but further investigation in necessary. 
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